DIAMYD MEDICAL AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.26 SEK | +5.43% |
|
+17.29% | +71.39% |
| 18/04 | Diamyd Medical Raises SEK57 Million in Rights Issue | MT |
| 12/04 | Recruitment Milestone Reaches in Diamyd® Phase 3 Trial | CI |
Chart calendar Diamyd Medical AB
6651ddb841b4620b7f6034d09715f9b.fsCCr_y3GkTnrJ23b2VLm9SjQSAU2GCvYJmRXux2A6s.FPLS96rTcA6R5MzzCTAKzIvWKXBTjRaXFezJE4MAWuE4gcrfre9Vc6z2rQ~f07bca101f6235cc6fa23892d315e3bf
Upcoming events on Diamyd Medical AB
Past events on Diamyd Medical AB
| 27/03/2024 | Q2 2024 Earnings Release |
| 24/01/2024 | Q1 2024 Earnings Release |
| 30/11/2023 | Annual General Meeting |
| 25/10/2023 | BioStock Life Science Fall Summit |
| 20/10/2023 05:30 pm | Business Update Call |
| 11/10/2023 | Q4 2023 Earnings Release |
| 28/06/2023 11:45 am | Q3 2023 Earnings Release |
| 26/06/2023 01:30 pm | Extraordinary Shareholder Meeting |
| 24/05/2023 09:30 am | Redeye Theme Diabetes Forum |
| 05/04/2023 | Q2 2023 Earnings Release |
| 25/01/2023 | Q1 2023 Earnings Release |
| 01/12/2022 | Annual General Meeting |
| 05/10/2022 | FY 2022 Earnings Release |
| 20/09/2022 | EASD Conference |
| 22/06/2022 11:45 am | Q3 2022 Earnings Release |
| 30/03/2022 | Interim 2022 Earnings Release |
| 26/01/2022 | Q1 2022 Earnings Release |
| 02/12/2021 | Annual General Meeting |
| 06/10/2021 | FY 2021 Earnings Release |
| 01/10/2021 04:00 pm | EASD Meeting |
Annual results
| Fiscal Period | August | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 1,64 1,00 63.7% | 1,13 0,50 125% | 0,25 0,60 -57.83% | 0,45 0,00 - | 19,6 3,00 553.73% | 3,00 |
|
EBITDA Million SEK | Released Forecast Spread | -36,4 -41,0 11.15% | 9,89 13,6 -27.29% | -85,1 -73,2 -16.25% | -112 -110 -2.21% | -100 -117 14.47% | -132 |
|
EBIT Million SEK | Released Forecast Spread | -36,6 -44,0 16.89% | 9,74 13,4 -27.32% | -85,9 -74,0 -16.05% | -115 -114 -0.82% | -105 -122 13.98% | -134 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -36,6 -44,0 16.8% | 9,71 14,2 -31.63% | 60,0 71,8 -16.37% | -104 -102 -1.49% | -100 -122 17.86% | -133 |
|
Net income Million SEK | Released Forecast Spread | -36,6 -44,0 16.8% | 9,71 14,2 -31.63% | 60,0 71,8 -16.37% | -104 -102 -1.49% | -100 -122 17.86% | -133 |
|
EPS SEK | Released Forecast Spread | -0,50 -0,62 19.35% | 0,10 0,20 -50% | 0,90 0,81 11.11% | -1,40 -1,30 -7.69% | -1,30 -1,42 8.45% | -1,33 |
| Announcement Date | 02/10/19 | 07/10/20 | 13/10/21 | 05/10/22 | 11/10/23 | - |
| Today 03:30 pm | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Diamyd Medical AB
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DMYD B Stock
- Calendar Diamyd Medical AB
